Lisa G. Wolf's most recent trade in Valion Bio Inc. was a trade of 92 Restricted Stock Units done . Disclosure was reported to the exchange on June 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Valion Bio Inc | Lisa G. Wolf | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2026 | 92 | 551 | - | - | Restricted Stock Units | |
| Valion Bio Inc | Lisa G. Wolf | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2026 | 92 | 618 | - | - | Common Stock | |
| Valion Bio Inc | Lisa G. Wolf | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2026 | 92 | 526 | - | - | Common Stock | |
| Valion Bio Inc | Lisa G. Wolf | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2026 | 92 | 643 | - | - | Restricted Stock Units | |
| Valion Bio Inc | Lisa G. Wolf | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2025 | 736 | 736 | - | - | Common Stock | |
| Valion Bio Inc | Lisa G. Wolf | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2025 | 736 | 735 | - | - | Restricted Stock Units | |
| Valion Bio Inc | Lisa G. Wolf | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.87 per share. | 18 Dec 2025 | 302 | 434 | - | 1.9 | 565 | Common Stock |
| Valion Bio Inc | Lisa G. Wolf | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 80,000 | 80,000 | - | - | Employee Stock Option (Right to Purchase) | |
| Valion Bio Inc | Lisa G. Wolf | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 80,000 | 80,000 | - | - | Employee Stock Option (Right to Purchase) | |
| Valion Bio Inc | Wolf Lisa G. | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2024 | 25,000 | 25,000 | - | - | Restricted Stock Units |